The link between interleukin-1β and acute myocardial infarction in chronic myeloid leukemia patients treated with nilotinib: cross-sectional study

Ann Hematol. 2020 Feb;99(2):359-361. doi: 10.1007/s00277-019-03896-4. Epub 2019 Dec 23.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aniline Compounds / therapeutic use
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Contraindications, Drug
  • Cross-Sectional Studies
  • Drug Substitution
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / pathology
  • Humans
  • Interleukin-1beta / blood*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Male
  • Middle Aged
  • Myocardial Infarction / chemically induced
  • Myocardial Infarction / etiology*
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism
  • Myocytes, Cardiac / pathology
  • Nitriles / therapeutic use
  • Protein Kinase Inhibitors / adverse effects*
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinase Inhibitors / therapeutic use
  • Pyrimidines / adverse effects*
  • Pyrimidines / pharmacology
  • Pyrimidines / therapeutic use
  • Quinolines / therapeutic use
  • Risk Factors

Substances

  • Aniline Compounds
  • Antineoplastic Agents
  • Interleukin-1beta
  • Nitriles
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Quinolines
  • bosutinib
  • nilotinib